The company’s share of imports could fall to 25% when an over-the-counter factory in North Carolina ... Reckitt and Abbott Laboratories, which is also defending such lawsuits, dispute the ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Abbott Laboratories (NYSE:ABT).

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Within three hours after Gov. Greg Abbott said Texas A&M University President Mark A Welsh III should lose his job and accused the university of violating the state's anti-diversity, equity and ...

Texas Gov. Greg Abbott on Monday announced that flags at the state Capitol building in Austin and at all state office buildings will be raised to full-staff next Monday, Jan. 20, to mark President ...